research use only

DCLK1-IN-1 Serine/threonin kinase inhibitor

Cat.No.S8976

DCLK1-IN-1 is a selective, in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1) domain that binds to DCLK1 and DCLK2 with IC50 of 9.5 nM and 31 nM, respectively. This compound inhibits DCLK1 and DCLK2 kinases with IC50 of 57.2 nM and 103 nM in kinase assay, respectively.
DCLK1-IN-1 Serine/threonin kinase inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 527.54

Jump to

Quality Control

Batch: S897601 DMSO]95 mg/mL]false]Water]Insoluble]false]Ethanol]Insoluble]false Purity: 99.71%
99.71

Solubility

In vitro
Batch:

DMSO : 95 mg/mL (180.08 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 527.54 Formula

C26H28F3N7O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 2222635-15-4 -- Storage of Stock Solutions

Synonyms N/A Smiles COC1=C(NC2=NC=C3N(CC(F)(F)F)C(=O)C4=CC=CC=C4N(C)C3=N2)C=CC(=C1)N5CCN(C)CC5

Mechanism of Action

Targets/IC50/Ki
DCLK1
(Cell-free assay)
9.5 nM
DCLK2
(Cell-free assay)
31 nM
DCLK1
(kinase assay)
57.2 nM
DCLK2
(kinase assay)
103 nM
In vitro

DCLK1-IN-1 displays pronounced on-target DCLK1 activity in vitro. This compound potently binds DCLK1 in HCT116 cells (IC50 = 279 nM). It significantly inhibits DCLK1, and weakly inhibits ERK5, in PATU-8988T cell lysates and live cells.

In vivo

DCLK1-IN-1 has a favorable pharmacokinetic profile in mice, with a half-life of 2.09 h, an area under the curve of 5,506 h ng−1 ml−1 and 81% oral bioavailability. This compound is well-tolerated at doses up to 100 mg kg−1 with no adverse effects and no loss of body weight observed in mice. It is a selective inhibitor of DCLK1, suitable for use as a chemical probe when used together with control compound DCLK1-NEG.

References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.